FGFR1 and breast ductal adenocarcinoma: Furthermore, through siRNA and a small-molecule inhibitor of FGFR1 (SU5402), they proved that inhibition of FGFR1 was capable of blocking survival of the ductal carcinoma cell line MDA-MB-134 [65].